Lorne Steinberg Wealth Management Inc. grew its holdings in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 0.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 233,155 shares of the medical equipment provider’s stock after purchasing an additional 2,160 shares during the period. Lorne Steinberg Wealth Management Inc. owned approximately 0.05% of Smith & Nephew worth $5,731,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Bleakley Financial Group LLC raised its holdings in Smith & Nephew by 3.5% in the 4th quarter. Bleakley Financial Group LLC now owns 17,704 shares of the medical equipment provider’s stock worth $435,000 after acquiring an additional 596 shares during the last quarter. First Trust Direct Indexing L.P. raised its holdings in Smith & Nephew by 6.9% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 9,659 shares of the medical equipment provider’s stock worth $301,000 after acquiring an additional 626 shares during the last quarter. Principal Securities Inc. raised its holdings in Smith & Nephew by 87.6% in the 4th quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 691 shares during the last quarter. GAMMA Investing LLC raised its holdings in Smith & Nephew by 31.8% in the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after acquiring an additional 718 shares during the last quarter. Finally, Townsquare Capital LLC raised its holdings in Smith & Nephew by 5.4% in the 3rd quarter. Townsquare Capital LLC now owns 14,759 shares of the medical equipment provider’s stock worth $460,000 after acquiring an additional 761 shares during the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.
Smith & Nephew Trading Up 1.0 %
NYSE:SNN opened at $25.95 on Wednesday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a 12 month low of $23.65 and a 12 month high of $31.72. The company has a 50 day simple moving average of $25.02 and a two-hundred day simple moving average of $27.37.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Smith & Nephew
About Smith & Nephew
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
Recommended Stories
- Five stocks we like better than Smith & Nephew
- Stock Market Upgrades: What Are They?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Are Penny Stocks a Good Fit for Your Portfolio?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What Do S&P 500 Stocks Tell Investors About the Market?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.